The uBCOs showed, in general, positivity for markers of urothelial differentiation (GATA-3, S100P), cytokeratins typically expressed in BC (AE1/AE3, CK5, CK 7, CK20), and for the proliferation marker Ki67. This evidence concerns the gene GATA3 and breast cancer.